Nuveen
VERA icon

Nuveen’s Vera Therapeutics VERA Stock Holding History

Nuveen’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8M Sell
298,410
-100,192
-25% -$3.73M ﹤0.01% 1538
2026
Q1 		$16M Buy
398,602
+171,521
+76% +$7.39M ﹤0.01% 1259
2025
Q4 		$11.5M Sell
227,081
-90,598
-29% -$3.22M ﹤0.01% 1475
2025
Q3 		$9.23M Buy
317,679
+208,712
+192% +$4.83M ﹤0.01% 1599
2025
Q2 		$2.57M Sell
108,967
-47,915
-31% -$1.08M ﹤0.01% 2188
2025
Q1 		$3.77M Buy
156,882
+1,057
+0.7% +$34K ﹤0.01% 2061
2024
Q4 		$6.59M Sell
155,825
-3,199
-2% -$142K ﹤0.01% 1847
2024
Q3 		$7.03M Buy
159,024
+17,177
+12% +$652K ﹤0.01% 1820
2024
Q2 		$5.13M Sell
141,847
-4,976
-3% -$197K ﹤0.01% 1939
2024
Q1 		$6.33M Sell
146,823
-51,361
-26% -$1.83M ﹤0.01% 1853
2023
Q4 		$3.05M Sell
198,184
-92,714
-32% -$1.18M ﹤0.01% 2218
2023
Q3 		$3.99M Buy
290,898
+123,432
+74% +$2.12M ﹤0.01% 1979
2023
Q2 		$2.69M Buy
167,466
+88,527
+112% +$800K ﹤0.01% 2216
2023
Q1 		$612K Sell
78,939
-19,197
-20% -$148K ﹤0.01% 2760
2022
Q4 		$1.9M Buy
98,136
+8,470
+9% +$153K ﹤0.01% 2409
2022
Q3 		$1.91M Buy
89,666
+15,344
+21% +$287K ﹤0.01% 2422
2022
Q2 		$1.01M Buy
74,322
+20,699
+39% +$361K ﹤0.01% 2774
2022
Q1 		$1.14M Buy
53,623
+38,525
+255% +$829K ﹤0.01% 2769
2021
Q4 		$344K Buy
+15,098
New +$334K ﹤0.01% 3149

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nuveen's VERA Position: Q2 2026 in Review

Nuveen reduced its Vera Therapeutics (VERA) stake by 25% in Q2 2026, selling an estimated $3.73M and leaving 298,410 shares worth $12.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1538.

Nuveen first reported a position in VERA in Q4 2021 and has held it in 19 quarters since. The position peaked at $16M in Q1 2026. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Nuveen held 298,410 shares of Vera Therapeutics worth $12.8M as of Q2 2026.
  • Nuveen sold 100,192 Vera Therapeutics shares in Q2 2026, an estimated $3.73M.
  • Vera Therapeutics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1538 holding.
  • Nuveen first reported a position in Vera Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Nuveen's Vera Therapeutics position peaked at $16M in Q1 2026.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.